Abeona Therapeutics
(ABEO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1992 | 09-1992 | 06-1992 | 03-1992 | 12-1991 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 4,254 | N/A | N/A | N/A | -680 |
| Depreciation Amortization | 30 | N/A | N/A | N/A | 23 |
| Other Working Capital | 449 | N/A | N/A | N/A | -470 |
| Other Operating Activity | 310 | 0 | 0 | 0 | 825 |
| Operating Cash Flow | $5,042 | $N/A | $N/A | $N/A | $-302 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -62 | N/A | N/A | N/A | -34 |
| Investing Cash Flow | $-62 | $N/A | $N/A | $N/A | $-34 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 43 | 0 | 0 | 0 | 9 |
| Financing Cash Flow | $43 | $N/A | $N/A | $N/A | $9 |
| Beginning Cash Position | 1,038 | N/A | N/A | N/A | 1,365 |
| End Cash Position | 6,060 | N/A | N/A | N/A | 1,038 |
| Net Cash Flow | $5,022 | $N/A | $N/A | $N/A | $-327 |
| Free Cash Flow | |||||
| Operating Cash Flow | 5,042 | N/A | N/A | N/A | -302 |
| Free Cash Flow | 5,042 | 0 | 0 | 0 | -302 |